Unknown EARLY_PHASE1 INTERVENTIONAL 2-arm NCT03120468

Topiramate Augmenting Strategies for the Treatment of Alcohol Use Disorder

Sponsor: Nassima Ait-Daoud Tiouririne

Interventions Topiramate and N-Acetyl Cysteine Topiramate and Placebo

Updated 9 times since 2017 Last updated: Oct 25, 2020 Started: May 1, 2017 Primary completion: Jan 31, 2021 Completion: Jan 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This EARLY_PHASE1 trial investigates Alcoholism and is currently ongoing. Nassima Ait-Daoud Tiouririne leads this study, which shows 9 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Unknown EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown EARLY_PHASE1

Status: Unknown Status → Unknown
Nov 2022 — Jul 2024 [monthly]

Unknown Status EARLY_PHASE1

Status: Active Not Recruiting → Unknown Status
Jan 2021 — Nov 2022 [monthly]

Active Not Recruiting EARLY_PHASE1
Nov 2020 — Jan 2021 [monthly]

Active Not Recruiting EARLY_PHASE1

Status: Unknown Status → Active Not Recruiting

▶ Show 4 earlier versions

May 2019 — Nov 2020 [monthly]

Unknown Status EARLY_PHASE1

Status: Recruiting → Unknown Status
Jun 2018 — May 2019 [monthly]

Recruiting EARLY_PHASE1
Aug 2017 — Jun 2018 [monthly]

Recruiting EARLY_PHASE1

Status: Not Yet Recruiting → Recruiting
Jun 2017 — Aug 2017 [monthly]

Not Yet Recruiting EARLY_PHASE1

First recorded

May 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Nassima Ait-Daoud Tiouririne

Data source: University of Virginia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Charlottesville, United States